Compare CTKB & FEIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTKB | FEIM |
|---|---|---|
| Founded | 1990 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.8M | 348.4M |
| IPO Year | 2021 | N/A |
| Metric | CTKB | FEIM |
|---|---|---|
| Price | $4.85 | $46.45 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $5.88 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 1.9M | 253.9K |
| Earning Date | 11-05-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 163.74 |
| EPS | N/A | ★ 2.17 |
| Revenue | ★ $196,828,000.00 | $69,852,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.62 | $17.90 |
| P/E Ratio | ★ N/A | $21.44 |
| Revenue Growth | N/A | ★ 16.06 |
| 52 Week Low | $2.37 | $13.69 |
| 52 Week High | $7.30 | $48.35 |
| Indicator | CTKB | FEIM |
|---|---|---|
| Relative Strength Index (RSI) | 47.20 | 80.83 |
| Support Level | $4.79 | $27.32 |
| Resistance Level | $5.16 | $36.48 |
| Average True Range (ATR) | 0.24 | 2.55 |
| MACD | -0.11 | 1.86 |
| Stochastic Oscillator | 9.57 | 95.56 |
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications. The company has FEI-NY and FEI-Zyfer reportable segments. It derives the majority of its revenues from the FEI-NY segment. FEI-NY segment operations consist principally of precision time and frequency control products used in three principal markets namely communication satellites (both commercial and U.S. Government-funded); terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military.